Google's EHR patient notification idea. Bayer-One Drop. Novartis-Pear.

Issue 038. Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a 60 percent open rate. Here's what's happening this week:

Welcome to all the new readers! Spikes in subscribers are always attributable to current readers mentioning E&O on Twitter or forwarding these newsletters to their smartest, most-accomplished colleagues. So, thanks for doing your part to spin this here flywheel with me...
Lots of great calls this week with current subscribers about trends in digital health (as well as conversations about ways to deepen and expand E&O). One particularly succinct line I heard sums up the tension digital health will have to navigate this decade: "There is no precision medicine without surveillance." 'Shivers down the spine' kind of one-liner.
Speaking of surveillance, Google Health has yet to reveal a health-sensing,

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Google’s EHR patient notification idea. Bayer-One Drop. Novartis-Pear.

Welcome to E&O.

Paying Subscribers Only

Full access to E&O's research and newsletters.

Google’s EHR patient notification idea. Bayer-One Drop. Novartis-Pear.

Welcome to E&O.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.